Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
WhiteHawk Minerals Corp. reported Q3 2026 financial results including record production of 71.3 MMcfe/d and net income of $6.9 million. Concurrently, the company announced the $41.0 million acquisition of mineral and royalty interests in the Marcellus/Appalachian Basin from Three Rivers Royalty II, LLC. The company also declared a quarterly dividend of $0.50 per share.
Counterparty
Three Rivers Royalty II, LLC
“Continuing the momentum, WhiteHawk is benefiting from its base business and two-pronged acquisition strategy, driving an increase in Cash Available for Distribution and net asset value. We continue to benefit directly from our best-in-class operators’ performance and growth potential. We are particularly excited by EQT’s pending acquisition of Range, which brings together two of our largest Appalachia operators. We believe the combined company’s scale, inventory depth and low-cost structure are well aligned with WhiteHawk’s interests and further support the long-term development of our core mineral position. At the same time, our two-pronged acquisition strategy continues to deliver. Since our IPO, we have signed 22 acquisitions totaling $157.3 million, including 20 ground game transactions totaling over $11 million. We believe these transactions, and execution on our acquisition pipeline, will continue to drive meaningful value for shareholders in the short, medium and long term.”
Daniel Herz, Chairman, President and Chief Executive Officer
PepGen Inc. entered into an underwriting agreement to sell 25,000,000 shares of common stock at a public offering price of $5.00 per share. The company expects to raise approximately $125.0 million in gross proceeds (excluding the underwriters' 30-day option for an additional 3.75 million shares) to fund clinical development and general corporate purposes.
Altimmune, Inc. reported a net loss of $77.0 million for the nine months ended September 30, 2026, compared to $60.7 million in the prior year, driven by increased research and development expenses. The company significantly strengthened its balance sheet through public and direct offerings, ending the period with $495.6 million in total assets, including $265.1 million in cash and investments.
Kiniksa Pharmaceuticals International CAO Michael R. Megna Sells $1.11M of Stock
Michael R. Megna, CAO, sold 11,280 shares of Kiniksa Pharmaceuticals International, plc at $98.54 a share, worth $1.11M in total on Nov 9, 2026. Shares held after the trade: 12,697 (-47.0%).
Frp Holdings CEO John D. Baker III Buys $99.1K of Stock
John D. Baker III, CEO, bought 5,263 shares of Frp Holdings, Inc. at $18.80 to $18.98 a share (average $18.84) in 2 transactions, worth $99.1K in total between Nov 10, 2026 and Nov 11, 2026. Shares held after the trade: 308,854 (+1.4%).
Standard Lithium Ltd. changed its functional currency from CAD to USD effective July 1, 2026, reflecting its advancing U.S. development projects. The company reported a carrying amount of $210.5 million for its equity method investment in the Smackover Lithium joint venture with Equinor as of September 30, 2026.
Net Power Inc. is a non-accelerated filer and emerging growth company focused on power generation technology. The filing highlights significant risks including a pause in Texas data center permits, the need for additional capital, and the full impairment of its La Porte Demonstration Facility assets.
First Keystone Corp reported a net income of $9.475 million for the nine months ended September 30, 2026, up from $6.775 million in the prior year period. Total assets grew significantly to $1.726 billion from $1.531 billion at year-end 2025, primarily driven by a $178 million increase in total deposits.
QuoteMedia Inc. reported a net loss of $1,140,614 for the nine months ended September 30, 2026, an improvement from the $1,720,585 loss in the prior year period. Revenue grew 11% to $16.6 million, while the company maintained a stockholders' deficit of $1,956,956 as of the end of the quarter.
Fluent, Inc. reported a net loss of $3.1 million for the third quarter of 2026, an improvement from a $7.6 million loss in the prior year period, driven by a 14% increase in revenue to $53.6 million. For the nine months ended September 30, 2026, the company generated $2.8 million in cash from operating activities compared to a $4.3 million outflow in 2025. Total shareholders' equity declined significantly from $18.2 million at the end of 2025 to $5.6 million as of September 30, 2026.
LifeStance Health Group M&A Deal with Selling Stockholders
LifeStance Health Group, Inc. entered into an underwriting agreement for a secondary offering of 45,000,000 shares of common stock sold by existing stockholders. The company did not receive any proceeds from the sale, but it repurchased 2,000,000 of these shares from the underwriters as part of the transaction.
Haas Sullivan, CAO, sold 2,427 shares of Magnite, Inc. at $29.59 a share, worth $71.8K in total on Nov 11, 2026. Shares held after the trade: 95,127 (-2.5%).
Senior management of USA Compression Partners, LP will attend a Texas Capital Securities investor event on November 17 and 18, 2026. The company will participate in meetings with the investment community and will post related presentation materials to its website prior to the event.
Upexi, Inc. reported fiscal first quarter 2027 results, highlighted by net income of $89.1 million, which was primarily driven by $102 million in unrealized gains on its digital asset treasury. The company significantly strengthened its balance sheet, reporting stockholders' equity of $49.2 million compared to a deficit in the prior quarter, and reduced its interest rate on BitGo borrowings from 11.5% to 7.5%.
Term
Q1 2027
“During the first quarter of fiscal 2027, we strengthened our balance sheet by increasing our Solana treasury to approximately 2.35 million SOL, increasing our cash on hand to $6.4 million, and increasing our stockholders’ equity to $49.2 million. Additionally, in September we successfully reduced the interest rate on our BitGo borrowings from 11.5% to 7.5%, a reduction we expect to lower annual interest expense by approximately $2.3 million.”
AVAX ONE TECHNOLOGY LTD. reported a net loss of $31.6 million for the nine months ended September 30, 2026, despite a significant increase in revenue to $7.8 million compared to $1.3 million in the prior year. The company's financial position was impacted by $10.9 million in unrealized losses on digital assets and $5.3 million in interest accretion on debentures, though it achieved a net income of $49.9 million in the third quarter due to a favorable market valuation swing of $55.1 million.
First Capital, Inc. reported net income of $14.2 million for the nine months ended September 30, 2026, up from $11.5 million in the prior year period, driven by higher net interest income. Total assets remained stable at $1.27 billion, while stockholders' equity decreased slightly to $135.7 million due to a significant increase in accumulated other comprehensive loss from unrealized losses on securities.
Illumina VP, CAO Scott D. Ericksen Sells $58.1K of Stock
Scott D. Ericksen, VP, CAO, sold 267 shares of Illumina, Inc. at $217.76 a share, worth $58.1K in total on Nov 10, 2026. Shares held after the trade: 14,029 (-1.9%).
Wilco 63 Corp reported net income of $1.95 million for the quarter ended September 30, 2026, primarily driven by $2.10 million in interest earned on marketable securities held in its Trust Account. As a blank check company, it has not yet commenced operations or generated revenue, and it currently holds $232.28 million in its Trust Account following its June 2026 initial public offering.
Steris Sr. Vice Pres., CFO Karen L. Burton Sells $1.5M of Stock
Karen L. Burton, Sr. Vice Pres., CFO, sold 5,880 shares of Steris plc at $255.62 a share, worth $1.5M in total on Nov 11, 2026. Shares held after the trade: 12,956 (-31.2%).
Mohsen Sohi sold 4,893 shares of Steris plc at $252.87 to $253.90 a share (average $253.22) in 2 transactions, worth $1.24M in total on Nov 10, 2026. Shares held after the trade: 24,305 (-6.4%).
GEN Restaurant Group reported a net loss of $17.3 million for the nine months ended September 30, 2026, compared to a $7.3 million loss in the prior year period, as restaurant operating expenses rose despite a slight decline in revenue. The company's total assets decreased to $247.2 million from $259.9 million at year-end 2025, while its cash position remained relatively stable at $2.9 million.
Virgin Galactic reported Q3 2026 financial results, including revenue of $0.4 million and a net loss of $59 million. The company announced plans for a $250 million at-the-market equity offering and potential debt-for-equity exchanges to fund operations and capacity expansion ahead of commercial flights expected in 2027.
Term
Q3 2026
“Spaceship Apeiron’s arrival at Spaceport America shifts our focus towards operational readiness, as we now prepare for flight test and the launch of commercial spaceflight. With our second spaceship on track to join Apeiron and Eve in late Q2/early Q3 2027, we have initiated near-term growth projects expected to increase capacity from this initial fleet to a rate of 150 spaceflights per year by the end of 2028.”
Michael Colglazier, Chief Executive Officer of Virgin Galactic
Lulu's Fashion Lounge Holdings, Inc. reported a significant decline in net revenue for the thirteen weeks ended September 27, 2026, falling to $58.6 million from $73.6 million in the prior year period. The company's stockholders' equity turned to a deficit of $5.0 million as of September 27, 2026, driven by an accumulated deficit of $272.0 million.
Quantum Cyber N.V. reported a significant increase in revenue to $0.97 million for the nine months ended September 30, 2026, compared to zero in the prior year, though net loss widened to $21.5 million. The company strengthened its balance sheet through $22.2 million in financing activities, primarily from warrant exercises and preferred share issuances, resulting in a total cash position of $4.89 million.
Sunshine Biopharma Inc. reported a net loss of $4.03 million for the nine months ended September 30, 2026, compared to a loss of $3.83 million in the prior year period. While revenues decreased slightly to $26.79 million, the company significantly strengthened its cash position to $14.62 million through public offerings and warrant exercises.
Aethlon Medical reported a net loss of $4.17 million for the six months ended September 30, 2026, compared to $3.25 million in the prior year period, driven largely by increased professional fees. The company is currently pursuing a merger with North Immunology, Inc. and has raised capital through common stock issuances to maintain a cash balance of approximately $6.49 million.
Willamette Valley Vineyards reported a net loss of $3.0 million for the nine months ended September 30, 2026, compared to a $1.7 million loss in the prior year period. Despite a 4.2% increase in net sales to $27.2 million, rising operating expenses and higher cost of sales contributed to a loss applicable to common shareholders of $0.97 per share.
BioStem Technologies reported a significant decline in revenue to $21.7 million for the nine months ended September 30, 2026, compared to $37.4 million in the prior year, resulting in a net loss from operations of $27.1 million. The company is facing liquidity challenges, including an unpaid $10 million clearance payment due to BioTissue and a substantial decrease in cash from $29.5 million to $971,145 over the nine-month period.
Olema Pharmaceuticals, Inc. has changed its corporate name to Olema Oncology, Inc. and relocated its principal executive offices to South San Francisco. The company's common stock will continue to trade on the Nasdaq Global Select Market under the existing ticker symbol OLMA.
For the nine months ended September 30, 2026, Eledon Pharmaceuticals reported a net loss of $74.6 million, a significant increase from the $35.2 million loss in the prior year period, primarily driven by a $11.6 million unfavorable change in the fair value of warrant liabilities. Total assets decreased to $106.6 million from $169.0 million at year-end 2025, reflecting a reduction in cash and short-term investments used to fund ongoing research and development operations.